Cytogenetic analysis of the bipotential murine pre-B cell lymphoma, P388, and its derivative macrophage-like tumor, P388D1, using SKY and CGH

Leukemia

Volumn 13, Issue 10, 1999, Pages 1592-1600

  Coleman, A E ^a   Forest, S T ^a   McNeil, N ^b   Kovalchuk, A L ^a   Ried, T ^b   Janz, S ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c DBS   (United States)

Author keywords

Bilineage differentiation potential; Karyotypic instability; Molecular cytogenetics; Phorbol ester induced cytogenetic changes

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IONOMYCIN; PHORBOL ESTER;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; CANCER GENETICS; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DNA SEQUENCE; GENETIC RECOMBINATION; KARYOTYPING; LEUKEMIA P 388; MARKER CHROMOSOME; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; STEM CELL;

EID: 0032884224     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401518     Document Type: Article

References (36)

1. Dawe A, Potter M. Morphologic and biologic progression of a lymphoid neoplasm of the mouse in vivo and in vitro. Am J Pathol 1957; 33: 603.
2. Bauer SR, Holmes KL, Morse HC, Potter M. Clonal relationship of the lymphoblastic cell line P388 to the macrophage cell line P388D1 as evidenced by immunoglobulin gene rearrangements and expression of cell surface antigens. J Immunol 1986; 136: 4695-4699.
3. Davidson WF, Pierce JH, Rudikoff S, Morse HC. Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med 1988; 168: 389-407.
4. Tanaka T, Wu GE, Paige CJ. Characterization of the B cell-macrophage lineage transition in 70Z/3 cells. Eur J Immunol 1994; 24: 1544-1548.
5. Martin M, Strasser A, Baumgarth N, Cicuttini FM, Welch K, Salvaris E, Boyd AW. A novel cellular model (SPGM 1) of switching between the pre-B cell and myelomonocytic lineages. J Immunol 1993; 150: 4395-4406.
6. Katoh S, Tominaga A, Migita M, Kudo A, Takatsu K. Conversion of normal Ly-1-positive B-lineage cells into Ly-1-positive macrophages in long-term bone marrow cultures. Dev Immunol 1990; 1: 113-125.
7. Borrello MA, Phipps RP. Fibroblasts support outgrowth of splenocytes simultaneously expressing B lymphocyte and macrophage characteristics. J Immunol 1995; 155: 4155-4161.
8. Venkatesan PV, Saravanan K, Nagarajan B. Characterization of multidrug resistance and monitoring of tumor response by combined 31P and 1H nuclear magnetic resonance spectroscopic analysis. Anticancer Drugs 1998; 9: 449-456.
9. Bomgaars L, Gunawardena S, Kelley SE, Ramu A. The inactivation of doxorubicin by long ultraviolet light. Cancer Chemother Pharmacol 1997; 40: 506-512.
10. Labourier E, Riou JF, Prudhomme M, Carrasco C, Bailly C, Tazi J. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity. Cancer Res 1999; 59: 52-55.
11. Dawe CJ. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties - discussion. Natl Cancer Inst Monogr 1968; 29: 229-232.
12. Barbour SE, Wong C, Rabah D, Kapur A, Carter AD. Mature macrophage cell lines exhibit variable responses to LPS. Mol Immunol 1998; 35: 977-987.
13. Alicea C, Belkowski SM, Sliker JK, Zhu J, Liu-Chen LY, Eisenstein TK, Adler MW, Rogers TJ. Characterization of kappa-opioid receptor transcripts expressed by T cell and macrophages. J Neuroimmunol 1998; 91: 55-62.
14. Kang JX, Bell J, Leaf A, Beard RL, Chandraratna RA. Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/ insulin-like growth factor II receptor and lysosomal enzymes. Proc Natl Acad Sci USA 1998; 95: 13687-13691.
15. Nordan RP, Potter M. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 1986; 233: 566-569.
16. Shacter E, Lopez RL, Beecham EJ, Janz S. DNA damage induced by phorbol ester-stimulated neutrophils is augmented by extracellular cofactors. Role of histidine and metals. J Biol Chem 1990; 265: 6693-6699.
17. Spencker T, Neumann D, Strasser A, Resch K, Martin M. Lineage switch of a mouse pre-B cell line (SPGM-1) to macrophage-like cells after incubation with phorbol ester and calcium ionophore. Biochem Biophys Res Commun 1999; 216: 540-548.
18. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow C, Wynshaw-Boris A, Janz S, Wienberg J, Ferguson-Smith MA, Schröck E, Ried T. Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 1996; 14: 312-315.
19. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. Multicolor spectral karyotyping of human chromosomes. Science 1996; 273: 494-497.
20. Shi YP, Naik P, Dietrich WF, Gray JW, Hanahan D, Pinkel D. DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice. Genes Chromosomes Cancer 1997; 19: 104-111.
21. Weaver ZA, McCormack SJ, Liyanage M, du Manoir S, Coleman A, Schröck E, Dickson RB, Ried T. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-myc transgenic mice. Genes Chromos Cancer 1999; 25: 251-260.
22. du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T. Quantitative analysis of comparative genomic hybridization. Cytometry 1995; 19: 27-41.
23. Rolink A, Haasner D, Nishikawa SI, Melchers F. Changes in frequencies of clonable preB cells during life in different lymphoid organs of mice. Blood 1993; 81: 2290-2300.
24. Ehrlich A, Martin V, Müller W, Rajewsky K. Analysis of the B-cell progenitor compartment at the level of single cells. Curr Biol 1994; 4: 573-583.
25. Kettleborough CA, Saldanha J, Ansell KH, Bendig MM. Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction. Eur J Immunol 1993; 23: 206-211.
26. Bentz M, Plesch A, Stilgenbauer S, Döhner H, Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 1998; 21: 172-175.
27. Borrello MA, Phipps RP. The B/macrophage cell: an elusive link between CD5+B lymphocytes and macrophages. Immunol Today 1996; 17: 471-475.
28. Ried T, Schröck E, Ning Y, Wienberg J. Chromosome painting: a useful art. Hum Mol Genet 1998; 7: 1619-1626.
29. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP. Genome screening by comparative genomic hybridization. Trends Genet 1997; 13: 405-409.
30. Yasseen AA, McKenna PG. Cytogenetic evidence for hemizygosity at the thymidine kinase locus in P388 mouse lymphoma cells. Experientia 1983; 39: 532-534.
31. Demidova NS, Chernova OB, Siyanova EY, Goncharova AS, Kopnin BP. Newly formed chromosome-like structures in independent mouse P388 sublines with developed in vivo mdr1 gene amplification. Somat Cell Mol Genet 1991; 17: 581-590.
32. Kopnin BP, Sokova OI, Demidova NS. Regularities of karyotypic evolution during stepwise amplification of genes determining drug resistance. Mutat Res 1992; 276: 163-177.
33. Kinzel V, Farber B, Petrusevska RT, Fusenig N. Cytogenetic effects of phorbol ester tumor promoters: possible role in multistep tumorigenesis. Prog Clin Biol Res 1990; 340D: 133-141.
34. Krishnaraju K, Hoffman B, Liebermann DA. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells. Blood 1998; 92: 1957-1966.
35. Klinken SP, Alexander WS, Adams JM. Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages. Cell 1988; 53: 857-867.
36. Cambier N, Zhang Y, Vairo G, Kosmopoulos K, Metcalf D, Nicola NA, Elefanty AG. Expression of BCR-ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation. Oncogene 1999; 18: 343-352.